Agenda

See our oligonucleotides and peptides tracks: click here below to expand the program

TRACK ON OLIGOS

14:00 – 14:25

Welcome – Networking and booth visiting

14:25 – 14:35

Welcome – Chairpersons

Brian Sproat
Chemconsilium GCV
Troels Koch 
MINA Therapeutics

14:35 – 15:05

Nucleic Acids as Household Medicine: Living in the World of RNA Therapeutics

Muthiah Manoharan
Alnylam Pharmaceuticals

15:05 – 15:25

Oligonucleotide HBEL-based manufacturing

Eduardo Paredes
Nitto Denko Avecia

15:25 – 15:40

Networking Carousel + booth visiting

15:40 – 16:00

Oligonucleotides & Chromatography – what's new

Patrick Endres
Tosoh Bioscience

16:00 – 16:25

Spherical Nucleic Acids Facilitate Efficient Local Delivery Across Therapeutic Areas

Matthias Schroff
Exicure

16:25 – 16:45

Coffee Break and Networking Carousel + booth visiting

16:45 – 17:10

Extra-hepatic delivery of Centyrin-targeted siRNA conjugates

Steven Nadler
Aro Biotherapeutics

17:10 – 17:35

Ugimers: PNAs with a modified backbone to adjust pharmacological properties

Thomas Lindhorst
UGISense

17:35 – 18:00

Oligonucleotide Therapeutics for Rare Diseases: Meeting the Quality Challenges at Warp Speed

Susan Srivatsa
ElixinPharma

18:00 – 18:30

Final remarks – Networking and booth visiting

14:00 – 14:25

Welcome – Networking and booth visiting

14:25 -14:35

Welcome – Chairpersons

Brian Sproat
Chemconsilium GCV
Troels Koch 
MINA Therapeutics

14:35 – 15:00

Liquid Phase Oligonucleotide Synthesis by Nanostar Sieving

Andrew Livingstone
Imperial College London

15:00 – 15:25

A novel, RNA-based anti-viral approach to limit BK virus propagation in immunocompromised patients

Eric van der Veer
Hybridize Therapeutics

15:25 – 15:45

The Future of Oncology Through the Lens of RNA

Zdravka Medarova
TransCode

15:45 – 16:10

Exploring new oligonucleotide backbone chemistries and their deployment to improve the properties of stereopure oligonucleotides

Pachamuthu Kandasamy
Wave Life Sciences

16:10 – 16:30

Coffee Break and Networking Carousel + booth visiting

16:30 – 16:55

Novel antisense therapy targeting microRNA-132 in heart failure: results of large animal studies and a first-in-human Phase 1b study

Janika Viereck
Cardior Pharmaceuticals

16:55 – 17:25

Capturing the Heart and Mind of Disease with RNA Targeting Technology

Richard S. Geary
Ionis Pharmaceuticals

17:25 – 18:05

Panel discussion – What do you see as the major technical challenges in the fast moving oligo therapeutics field?

18:05 – 18:30

Final remarks – Networking and booth visiting

TRACK ON PEPTIDES

14:00 – 14:25

Welcome – Networking and booth visiting

14:25 – 14:35

Welcome – Chairpersons

Fernando Albericio 
University of Barcelona 
Sara Pellegrino
University of Milan

14:35 – 15:05

Greening Solid Phase Peptide Synthesis: Challenges Ahead

Walter Cabri
Fresenius Kabi & University of Bologna

15:05 – 15:25

Development, optimization and scale up of therapeutic peptides: approaches to solid phase synthesis.

Andrew Kennedy
Gyros Protein Technologies

15:25 – 15:40

Networking Carousel + booth visiting

15:40 – 16:00

Innovation in chromatography processes: Cyclojet (isocratic binary separation) and GSSR (Gradient Central Cut Separation) as tools for complex tides separation

Lisa Audoy
Novasep

16:00 – 16:25

Fluorescent cyclic peptides for cell imaging

Marc Vendrell
University of Edinburgh

16:25 – 16:45

Coffee Break and Networking Carousel + booth visiting

16:45 – 17:10

Green Peptide Manufacturing: when a constraint becomes an opportunity

Olivier Ludemann-Hombourger
PolyPeptide Group

17:10 – 17:35

The Intelligent Repurposing™ of Glycopeptides to Target Urgent Threat Bacterial Pathogens

Jacob Rendell
SuperTrans Medical

17:35 – 18:00

Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives

Alessandra Tolomelli
University of Bologna

18:00 – 18:30

Final remarks – Networking and booth visiting

14:00 – 14:25

Welcome – Networking and booth visiting

14:25 – 14:35

Welcome – Chairpersons

Fernando Albericio 
University of Barcelona 
Sara Pellegrino
University of Milan

14:35 – 15:00

High-throughput discovery and parallel optimization of peptide therapeutics

Lauren Goodrich
Nimble Therapeutics

15:00 – 15:25

Orthogonal Purification of Peptides by IEX-RP Chromatography

Alessandra Basso
Purolite

15:25 – 15:45

Late Stage Functionalization of Histidine in Peptides

Anaïs F. M. Noisier
AstraZeneca

15:45 – 16:10

Optimizing the Pharmacokinetic Profile of Peptides by Novel “Fatty” Amino Acids

Thomas Bruckdorfer
Iris Biotech

16:10 – 16:30

Coffee Break and Networking Carousel + booth visiting

16:30 – 16:55

Peptide Easy Clean – a technology platform for novel peptide vaccines

Dominik Sarma
Belyntic

16:55 – 17:25

Refractometry to control the peptide synthesis

Beatriz G. de la Torre
University of KwaZulu-Natal
John Lopez
Novartis

17:25 – 18:05

Panel discussion – What do you see as the major technical challenges in the fast moving peptide therapeutics field?

18:05 – 18:30

Final remarks – Networking and booth visiting